OTC · PVTTF
Pivotal Therapeutics Inc.
$0.00+$0.00 (+179,899.98%)
Pivotal Therapeutics Inc.’s quoted price sits in the lower half of its reported 52-week range, 14.29% below the high.
Loading market information…
OTC · ALDNF · USD
Stock price
Quote as of Oct 3, 2024, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Aladdin Healthcare Technologies SE, operating through its subsidiary Aladdin Healthcare Technologies Ltd, develops advanced software solutions for the secure storage and management of health information, prominently featuring blockchain technology. The company's core competencies lie in cutting-edge fields such as blockchain, machine learning, and artificial intelligence. Among its innovative offerings is an Artificial Intelligence Early Diagnosis platform, utilizing AI for the sophisticated analysis of brain imaging. Another significant product is its Health Risk Assessment platform, designed to evaluate patients' susceptibility to cardiovascular, diabetic, and kidney-related conditions. Furthermore, Aladdin Healthcare Technologies is pioneering an Artificial Intelligence-assisted Drug Discovery platform, which aims to pinpoint novel small molecule drug compounds for a range of age-related illnesses, including Alzheimer's and Parkinson's, as well as SARS-CoV-2. Leveraging blockchain, machine learning, artificial intelligence, and advanced predictive data analytics, the company is committed to facilitating the early detection of chronic diseases. Established in 2014, Aladdin Healthcare Technologies SE is headquartered in Berlin, Germany.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:20 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00+$0.00 (+179,899.98%)
Pivotal Therapeutics Inc.’s quoted price sits in the lower half of its reported 52-week range, 14.29% below the high.
$0.00+$0.00 (0.0%)
Advanced Proteome Therapeutics Corporation: Healthcare · Biotechnology.
$0.00+$0.00 (+9,900.0%)
MedMen Enterprises Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00-$0.00 (-90.0%)
RedHawk Holdings Corp.: Healthcare · Medical - Devices.
$0.00+$0.00 (+400.0%)
QuantRx Biomedical Corporation’s quoted price sits in the lower half of its reported 52-week range, 87.5% below the high.
$0.02-$0.00 (-5.0%)
Mycotopia Therapies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 89.44% below the high.
$0.00+$0.00 (+29,900.0%)
Miravant Medical Technologies Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00-$0.05 (-99.6%)
StatSure Diagnostic Systems, Inc.: Healthcare · Medical - Devices.
